PRESS RELEASE published on 08/27/2024 at 07:30, 2 years ago Dermapharm Holding SE: High-margin existing business in branded pharmaceuticals segment drives organic growth at German and international companies Dermapharm Holding SE reports 7.3% rise in unadjusted EBITDA to EUR 147.0 million, driven by organic growth in branded pharmaceuticals segment. High-revenue expected in H2. Full report at https://ir.dermapharm.de/en EBITDA Revenue Forecast Organic Growth Dermapharm Holding SE Branded Pharmaceuticals
BRIEF published on 08/14/2024 at 07:35, 2 years ago Croissance organique soutenue dans le secteur pharmaceutique à forte marge EBITDA Médicaments Revenu Dermapharm Premier Semestre 2024
BRIEF published on 08/14/2024 at 07:35, 2 years ago Sustained Organic Growth in High-Margin Pharmaceutical Business EBITDA Revenue Pharmaceuticals H1 2024 Dermapharm
PRESS RELEASE published on 08/14/2024 at 07:30, 2 years ago Sustained organic growth in high-margin existing branded pharmaceutical business Dermapharm Holding SE reports sustained organic growth in high-margin existing branded pharmaceutical business, with year-on-year drop in revenue and EBITDA in first half of 2024 Financial Results 2024 Outlook Organic Growth Dermapharm Holding SE Branded Pharmaceuticals
BRIEF published on 06/27/2024 at 18:20, 2 years 2 months ago Dermapharm Holding SE : l'Assemblée générale annuelle décide de distribuer un dividende de 0,88 EUR par action Dividende Assemblée Générale Annuelle Perspectives Financières Dermapharm
BRIEF published on 06/27/2024 at 18:20, 2 years 2 months ago Dermapharm Holding SE: Annual General Meeting Resolves Dividend Distribution of EUR 0.88 Per Share Annual General Meeting Dividend Financial Outlook Dermapharm
PRESS RELEASE published on 06/27/2024 at 18:15, 2 years 2 months ago Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share Dermapharm Holding SE's Annual General Meeting approves EUR 0.88 per share dividend distribution for 2024. Board actions confirmed. Outlook and acquisitions strategies highlighted Annual General Meeting Acquisitions Outlook Dividend Distribution Dermapharm Holding SE
BRIEF published on 05/15/2024 at 07:35, 2 years 3 months ago Dermapharm Holding SE annonce une baisse de son chiffre d'affaires au premier trimestre 2024 dans un contexte de forte croissance des produits pharmaceutiques de marque Résultats Financiers Croissance Organique Résilience Du Marché Produits De Santé Produits Pharmaceutiques De Marque
BRIEF published on 05/15/2024 at 07:35, 2 years 3 months ago Dermapharm Holding SE Reports Decline in Q1 2024 Revenue Amidst Strong Branded Pharmaceuticals Growth Financial Results Organic Growth Market Resilience Healthcare Products Branded Pharmaceuticals
PRESS RELEASE published on 05/15/2024 at 07:30, 2 years 3 months ago Strong organic growth in core markets underscores resilience of Dermapharm Holding SE's corporate strategy Dermapharm Holding SE reports strong organic growth in core markets with resilient corporate strategy in Q1 2024 Organic Growth Q1 2024 Core Markets Dermapharm Holding SE Resilient Strategy
Published on 08/28/2026 at 08:05, 4 hours 54 minutes ago Caledonia Mining Corporation Plc: Maiden Mineral Resource Estimate at Motapa 379,000 oz Measured and Indicated; 131,000 oz Inferred
Published on 08/28/2026 at 08:05, 4 hours 54 minutes ago Tocvan Announces New Surface Mineralization in Several Zones at Gran Pilar Gold-Silver Project
Published on 08/28/2026 at 08:00, 4 hours 59 minutes ago Caledonia Mining Corporation Plc: Blanket Mine Underground Measured and Indicated Mineral Resources Estimate Increases by 22% to 2.18 Million Ounces and Declaration of a Surface Mineral Resource Estimate
Published on 08/28/2026 at 04:30, 8 hours 29 minutes ago Snipp Interactive Reports Q2 2026 Financial Results; Returns to Positive EBITDA on Highest Quarterly Revenue in Five Quarters
Published on 08/27/2026 at 23:05, 13 hours 54 minutes ago Galway Metals Announces Filing of NI 43-101 Technical Report for Updated Clarence Stream Mineral Resource Estimate
Published on 08/28/2026 at 12:43, 15 minutes ago Annual General Meeting of MPC Capital AG approves change of name to MPC Oceanic Group AG
Published on 08/28/2026 at 12:43, 16 minutes ago IVU and Hellenic Train collaborate to enhance Rail Mobility in Greece
Published on 08/28/2026 at 11:15, 1 hour 44 minutes ago Redcare Pharmacy announces Managing Board succession: Peter Schmid von Linstow to succeed Olaf Heinrich as part of a planned leadership transition.
Published on 08/28/2026 at 11:12, 1 hour 46 minutes ago EQS-Adhoc: Redcare Pharmacy N.V.: Change in the Managing Board; Peter Schmid von Linstow to become Chief Executive Officer.
Published on 08/26/2026 at 18:02, 1 day 18 hours ago Altareit: Altarea press release regarding the Primonial matter
Published on 08/26/2026 at 18:02, 1 day 18 hours ago Altareit : Communiqué de presse d’Altarea relatif au dossier Primonial
Published on 08/26/2026 at 18:00, 1 day 18 hours ago Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
